{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:17:38Z","timestamp":1768594658568,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institutes of Neurological Disorders and Stroke","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11910-019-0950-y","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T07:03:55Z","timestamp":1557817435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Early Secondary Prevention in Transient Ischemic Attack (TIA) and Minor Stroke"],"prefix":"10.1007","volume":"19","author":[{"given":"Dominic","family":"Tse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelagh B.","family":"Coutts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"6","key":"950_CR1","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"JD Easton","year":"2009","unstructured":"Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276\u201393. \n                      https:\/\/doi.org\/10.1161\/STROKEAHA.108.192218\n                      \n                    .","journal-title":"Stroke."},{"issue":"21","key":"950_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMsb020987","volume":"347","author":"GW Albers","year":"2002","unstructured":"Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, et al. Transient ischemic attack\u2014proposal for a new definition. N Engl J Med. 2002;347(21):1713\u20136. \n                      https:\/\/doi.org\/10.1056\/NEJMsb020987\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"4","key":"950_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.03.006","volume":"22","author":"TH Park","year":"2013","unstructured":"Park TH, Hong KS, Choi JC, Song P, Lee JS, Lee J, et al. Validation of minor stroke definitions for thrombolysis decision making. J Stroke Cerebrovasc Dis. 2013;22(4):482\u201390. \n                      https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2013.03.006\n                      \n                    .","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"950_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/STROKEAHA.109.572883","volume":"41","author":"U Fischer","year":"2010","unstructured":"Fischer U, Baumgartner A, Arnold M, Nedeltchev K, Gralla J, De Marchis GM, et al. What is a minor stroke? Stroke. 2010;41(4):661\u20136. \n                      https:\/\/doi.org\/10.1161\/STROKEAHA.109.572883\n                      \n                    .","journal-title":"Stroke."},{"issue":"3","key":"950_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/ijs.12426","volume":"10","author":"AY Yu","year":"2015","unstructured":"Yu AY, Hill MD, Coutts SB. Should minor stroke patients be thrombolyzed? A focused review and future directions. Int J Stroke. 2015;10(3):292\u20137. \n                      https:\/\/doi.org\/10.1111\/ijs.12426\n                      \n                    .","journal-title":"Int J Stroke"},{"issue":"3","key":"950_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/STROKEAHA.116.015417","volume":"48","author":"D Degan","year":"2017","unstructured":"Degan D, Ornello R, Tiseo C, De Santis F, Pistoia F, Carolei A, et al. Epidemiology of transient ischemic attacks using time- or tissue-based definitions: a population-based study. Stroke. 2017;48(3):530\u20136. \n                      https:\/\/doi.org\/10.1161\/STROKEAHA.116.015417\n                      \n                    .","journal-title":"Stroke."},{"issue":"483","key":"950_CR7","first-page":"813","volume":"52","author":"F Buntinx","year":"2002","unstructured":"Buntinx F, Devroey D, Van Casteren V. The incidence of stroke and transient ischaemic attacks is falling: a report from the Belgian sentinel stations. Br J Gen Pract. 2002;52(483):813\u20137.","journal-title":"Br J Gen Pract"},{"issue":"9425","key":"950_CR8","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0140-6736(04)16405-2","volume":"363","author":"PM Rothwell","year":"2004","unstructured":"Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford vascular study). Lancet. 2004;363(9425):1925\u201333. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(04)16405-2\n                      \n                    .","journal-title":"Lancet."},{"issue":"11","key":"950_CR9","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1161\/STROKEAHA.114.006575","volume":"45","author":"V Sundararajan","year":"2014","unstructured":"Sundararajan V, Thrift AG, Phan TG, Choi PM, Clissold B, Srikanth VK. Trends over time in the risk of stroke after an incident transient ischemic attack. Stroke. 2014;45(11):3214\u20138. \n                      https:\/\/doi.org\/10.1161\/STROKEAHA.114.006575\n                      \n                    .","journal-title":"Stroke."},{"issue":"4","key":"950_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/cjn.2016.305","volume":"44","author":"AYX Yu","year":"2017","unstructured":"Yu AYX, Lindsay MP, Kamal N, Fang J, Coutts SB, Hill MD. Shifting trend of transient ischemic attack admission and prognosis in Canada. Can J Neurol Sci. 2017;44(4):391\u20136. \n                      https:\/\/doi.org\/10.1017\/cjn.2016.305\n                      \n                    .","journal-title":"Can J Neurol Sci"},{"issue":"22","key":"950_CR11","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","volume":"284","author":"SC Johnston","year":"2000","unstructured":"Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901\u20136.","journal-title":"JAMA."},{"issue":"12","key":"950_CR12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","volume":"6","author":"MF Giles","year":"2007","unstructured":"Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063\u201372. \n                      https:\/\/doi.org\/10.1016\/S1474-4422(07)70274-0\n                      \n                    .","journal-title":"Lancet Neurol"},{"issue":"22","key":"950_CR13","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/archinte.167.22.2417","volume":"167","author":"CM Wu","year":"2007","unstructured":"Wu CM, McLaughlin K, Lorenzetti DL, Hill MD, Manns BJ, Ghali WA. Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med. 2007;167(22):2417\u201322. \n                      https:\/\/doi.org\/10.1001\/archinte.167.22.2417\n                      \n                    .","journal-title":"Arch Intern Med"},{"issue":"23","key":"950_CR14","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","volume":"378","author":"P Amarenco","year":"2018","unstructured":"Amarenco P, Lavallee PC, Monteiro Tavares L, Labreuche J, Albers GW, Abboud H, et al. Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med. 2018;378(23):2182\u201390. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1802712\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"10","key":"950_CR15","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1503\/cmaj.101668","volume":"183","author":"JJ Perry","year":"2011","unstructured":"Perry JJ, Sharma M, Sivilotti ML, Sutherland J, Symington C, Worster A, et al. Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack. CMAJ. 2011;183(10):1137\u201345. \n                      https:\/\/doi.org\/10.1503\/cmaj.101668\n                      \n                    .","journal-title":"CMAJ."},{"issue":"10","key":"950_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1212\/WNL.0b013e31825f9d02","volume":"79","author":"LM Sanders","year":"2012","unstructured":"Sanders LM, Srikanth VK, Blacker DJ, Jolley DJ, Cooper KA, Phan TG. Performance of the ABCD2 score for stroke risk post TIA: meta-analysis and probability modeling. Neurology. 2012;79(10):971\u201380. \n                      https:\/\/doi.org\/10.1212\/WNL.0b013e31825f9d02\n                      \n                    .","journal-title":"Neurology."},{"issue":"4","key":"950_CR17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1161\/STROKEAHA.111.637421","volume":"43","author":"SB Coutts","year":"2012","unstructured":"Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD, et al. CT\/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke. 2012;43(4):1013\u20137. \n                      https:\/\/doi.org\/10.1161\/STROKEAHA.111.637421\n                      \n                    .","journal-title":"Stroke."},{"issue":"11","key":"950_CR18","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1161\/STROKEAHA.112.665141","volume":"43","author":"SB Coutts","year":"2012","unstructured":"Coutts SB, Modi J, Patel SK, Aram H, Demchuk AM, Goyal M, et al. What causes disability after transient ischemic attack and minor stroke?: results from the CT and MRI in the triage of TIA and minor cerebrovascular events to identify high risk patients (CATCH) study. Stroke. 2012;43(11):3018\u201322. \n                      https:\/\/doi.org\/10.1161\/STROKEAHA.112.665141\n                      \n                    .","journal-title":"Stroke."},{"issue":"11","key":"950_CR19","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/01.WNL.0000129482.70315.2F","volume":"62","author":"MD Hill","year":"2004","unstructured":"Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology. 2004;62(11):2015\u201320.","journal-title":"Neurology."},{"issue":"4","key":"950_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1017\/S0317167100007770","volume":"36","author":"CM Wu","year":"2009","unstructured":"Wu CM, Manns BJ, Hill MD, Ghali WA, Donaldson C, Buchan AM. Rapid evaluation after high-risk TIA is associated with lower stroke risk. Can J Neurol Sci. 2009;36(4):450\u20135.","journal-title":"Can J Neurol Sci"},{"issue":"9596","key":"950_CR21","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/S0140-6736(07)61448-2","volume":"370","author":"PM Rothwell","year":"2007","unstructured":"Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370(9596):1432\u201342. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(07)61448-2\n                      \n                    .","journal-title":"Lancet."},{"issue":"9431","key":"950_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"HC Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331\u20137. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(04)16721-4\n                      \n                    .","journal-title":"Lancet."},{"issue":"16","key":"950_CR23","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa060989","volume":"354","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706\u201317. \n                      https:\/\/doi.org\/10.1056\/NEJMoa060989\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"11","key":"950_CR24","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","volume":"6","author":"J Kennedy","year":"2007","unstructured":"Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6(11):961\u20139. \n                      https:\/\/doi.org\/10.1016\/S1474-4422(07)70250-8\n                      \n                    .","journal-title":"Lancet Neurol"},{"issue":"1","key":"950_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"\u2022\u2022 Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11\u20139. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1215340\n                      \n                     Randomized trial of dual antiplatelet therapy in patients with TIA or minor stroke.","journal-title":"N Engl J Med"},{"issue":"1","key":"950_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.114.014791","volume":"132","author":"Y Wang","year":"2015","unstructured":"Wang Y, Pan Y, Zhao X, Li H, Wang D, Johnston SC, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes. Circulation. 2015;132(1):40\u20136. \n                      https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.014791\n                      \n                    .","journal-title":"Circulation."},{"issue":"3","key":"950_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"\u2022\u2022 Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215\u201325. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1800410\n                      \n                     Randomized trial of dual antiplatelet therapy in patients with TIA or minor stroke.","journal-title":"N Engl J Med"},{"issue":"2_suppl","key":"950_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1747493018802481","volume":"13","author":"World Stroke Congress Abstracts","year":"2018","unstructured":"\u2022 World Stroke Congress Abstracts. Late breaking submissions. Int J Stroke. 2018;13(2_suppl):225\u201344. \n                      https:\/\/doi.org\/10.1177\/1747493018802481\n                      \n                     Secondary analysis of POINT.","journal-title":"Int J Stroke"},{"issue":"10123","key":"950_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(17)32849-0","volume":"391","author":"PM Bath","year":"2018","unstructured":"Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, et al. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet. 2018;391(10123):850\u20139. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(17)32849-0\n                      \n                    .","journal-title":"Lancet."},{"issue":"1\u20132","key":"950_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","volume":"143","author":"HC Diener","year":"1996","unstructured":"Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143(1\u20132):1\u201313.","journal-title":"J Neurol Sci"},{"issue":"8","key":"950_CR31","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.STR.21.8.1122","volume":"21","author":"European Stroke Prevention Study","year":"1990","unstructured":"European Stroke Prevention Study. ESPS group. Stroke. 1990;21(8):1122\u201330.","journal-title":"Stroke."},{"issue":"9523","key":"950_CR32","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5.","volume":"367","author":"PH Halkes","year":"2006","unstructured":"Group ES, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367(9523):1665\u201373. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(06)68734-5.","journal-title":"Lancet."},{"issue":"12","key":"950_CR33","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","volume":"359","author":"RL Sacco","year":"2008","unstructured":"Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359(12):1238\u201351. \n                      https:\/\/doi.org\/10.1056\/NEJMoa0805002\n                      \n                    .","journal-title":"N Engl J Med"},{"key":"950_CR34","volume-title":"Dual antiplatelet therapy using cilostazol for high-risk ischemic stroke: the cilostazol stroke prevention study for antiplatelet combination (CSPS.com). International stroke conference; 2019 February 6","year":"2019","unstructured":"Toyoda K, Uchiyama S, Hoshino H, Kimura K, Minematsu K, Origasa H, et al., editors. Dual antiplatelet therapy using cilostazol for high-risk ischemic stroke: the cilostazol stroke prevention study for antiplatelet combination (CSPS.com). International stroke conference; 2019 February 6. Honolulu: American Stroke Association; 2019."},{"issue":"3","key":"950_CR35","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49(3):e46\u2013e110. \n                      https:\/\/doi.org\/10.1161\/STR.0000000000000158\n                      \n                    .","journal-title":"Stroke."},{"issue":"9","key":"950_CR36","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1177\/1747493018786616","volume":"13","author":"JM Boulanger","year":"2018","unstructured":"Boulanger JM, Lindsay MP, Gubitz G, Smith EE, Stotts G, Foley N, et al. Canadian stroke best practice recommendations for acute stroke management: prehospital, emergency department, and acute inpatient stroke care, 6th edition, update 2018. Int J Stroke. 2018;13(9):949\u201384. \n                      https:\/\/doi.org\/10.1177\/1747493018786616\n                      \n                    .","journal-title":"Int J Stroke"},{"issue":"12","key":"950_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2165\/00003088-200241120-00002","volume":"41","author":"Z Desta","year":"2002","unstructured":"Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet. 2002;41(12):913\u201358. \n                      https:\/\/doi.org\/10.2165\/00003088-200241120-00002\n                      \n                    .","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"950_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","volume":"316","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao X, Lin J, Li H, Johnston SC, Lin Y, et al. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA. 2016;316(1):70\u20138. \n                      https:\/\/doi.org\/10.1001\/jama.2016.8662\n                      \n                    .","journal-title":"JAMA."},{"issue":"9","key":"950_CR39","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","volume":"27","author":"S Husted","year":"2006","unstructured":"Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. Eur Heart J. 2006;27(9):1038\u201347. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehi754\n                      \n                    .","journal-title":"Eur Heart J"},{"issue":"1","key":"950_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1603060","volume":"375","author":"SC Johnston","year":"2016","unstructured":"Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med. 2016;375(1):35\u201343. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1603060\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"4","key":"950_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1474-4422(17)30038-8","volume":"16","author":"P Amarenco","year":"2017","unstructured":"Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, et al. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol. 2017;16(4):301\u201310. \n                      https:\/\/doi.org\/10.1016\/S1474-4422(17)30038-8\n                      \n                    .","journal-title":"Lancet Neurol"},{"issue":"3","key":"950_CR42","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(18)30449-6","volume":"18","author":"A Ogawa","year":"2019","unstructured":"Ogawa A, Toyoda K, Kitagawa K, Kitazono T, Nagao T, Yamagami H, et al. Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I). Lancet Neurol. 2019;18(3):238\u201347. \n                      https:\/\/doi.org\/10.1016\/S1474-4422(18)30449-6\n                      \n                    .","journal-title":"Lancet Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-0950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-019-0950-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-0950-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:58:22Z","timestamp":1589738302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-019-0950-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s11910-019-0950-y","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"14 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dominic Tse declares no potential conflicts of interest. Shelagh Coutts received research\/grant support from the Canadian Institutes of Health Research (CRH-112319), the Heart and Stroke Foundation of Canada (G-16-00012585), and Genome Canada (143TIA-Penn). Michael D. Hill reports payment for serving as a stroke outcome event adjudicator for a panel of clinical trials from Merck; reports non-financial support for a drug received as in-kind support for a clinical trial\u2014TEMPO-1 trial, 2013\u20132016 from Hoffmann-La Roche Canada Ltd.; reports grant to the University of Calgary support the ESCAPE trial 2012\u20132014 from Covidien (Medtronic); reports grant to the University of Calgary support the TEMPO-2 trial 2016-present; Advisory board for the COLUMBUS registry from Boehringer-Ingleheim; reports grant to the University of Calgary to support the UNMASK-EVT study 2017\u2013present from Stryker Inc.; reports grant to the University of Calgary for the HERMES collaboration 2016-present from Medtronic LLC; reports grant to the University of Calgary to support the ESCAPE-NA1 study 2017-present from NoNO Inc., outside the submitted work. In addition, Dr. Hill has a patent Systems and Methods for Assisting in Decision-Making and Triaging for Acute Stroke Patients pending to US Patent office Number: 62\/086,077 and owns stock in Calgary Scientific Incorporated, a company that focuses on medical imaging software, is also a director of the Canadian Federation of Neurological Sciences, a not-for-profit group and has received grant support from Alberta Innovates Health Solutions, CIHR, Heart & Stroke Foundation of Canada, and National Institutes of Neurological Disorders and Stroke.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"34"}}